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Abstract We used a '~2P-labeled pCMV-CAT plasmid DNA to 
estimate the DNA uptake efficiency and unlabeled pCMV-CAT 
plasmid DNA to quantify the CAT activity after transfection of 
COS cells using each of the three following cationic compounds: 
[1] vectamidine (3-tetradecylamino-N-tert-butyl-N'-tetradecyl- 
propionamidine, and previously described as diC14-amidine 
[1]), [2] lipofectin (a 1:1 mixture of N-(l-2,3-dioleyloxypropyl)- 
N,N,N-triethylammonium (DOTMA) and dioleyiphosphatid- 
ylethanolamine (DOPE)), and [3] DMRIE-C (a l : l  mixture of 
N-[1-(2,3-dimyristyloxy)propyl]-N,N-dimethyI-N-(2-hydroxy- 
ethyl) ammonium bromide (DMRIE) and cholesterol). Surpris- 
ingly, a high CAT activity was observed with vectamidine 
although the DNA uptake efficiency was lower as compared to 
lipofectin and DMRIE-C. Transmission electron microscopy 
(TEM) revealed endocytosis as the major pathway of DNA- 
cationic lipid complex entry into COS cells for the three cationic 
lipids. However, the endosomal membrane in contact with 
complexes containing vectamidine or DMRIE-C often exhibited 
a disrupted morphology. This disruption of endosomes was much 
less frequently observed with the DNA-lipofectin complexes. 
This comparison of the three compounds demonstrate that 
efficient transfection mediated by cationic lipids is not only 
correlated to their percentage of uptake but also to their ability 
to destabilize and escape from endosomes. 
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1. Introduction 
Synthetic ationic lipids have been used extensively to facil- 
itate delivery of DNA [1 6], mRNA [7,8], oligonucleotides [9]
and proteins [10,11] into cultured cells. They have also been 
tested successfully for direct gene transfer into animals [12 -14] 
and some of them are being evaluated in humans under clin- 
ical trials [15 17]. Their common structure is composed of an 
hydrophobic moiety (usually two hydrocarbon chains) and 
one positively charged headgroup. Most of them tend to 
form liposomes, much like phospholipids, when dispersed in 
an aqueous phase. Despite their wide use and potential appli- 
cations as vectors for gene therapy, it is only recently that 
serious attempts have been made to better understand their 
mechanism of action. Successive and distinct steps are in- 
volved in cationic lipid-mediated gene delivery. Early steps, 
including the initial interaction of the cationic liposome with 
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the DNA to fl~rm a complex [18 21] and internalization f the 
complexed DNA by the cell [22 27], are relatively well char- 
acterized. Release of DNA from the complex [28] and its 
accessibility to the transcription apparatus are still poorly 
understood. Endocytosis has been suggested as the main path- 
way of DNA cationic lipid complex iqternalization bythe cell 
[22 27] and the efficiency of this step has been proposed to be 
an important rate-limiting factor in transfection [24,25]. Re- 
cent studies have concluded that early escape of the complex 
from the endosomal/lysosomal compartment is crucial t\~r ef- 
ficient gene transfer and expression [23,26]. Indeed, entry of 
the complex into the lysosomal compartment has been sug- 
gested to cause massive DNA degradation and to prevent 
transfection. However, the relative importance of each step 
(efficiency of complex uptake by endocytosis and escape 
from endosomes) in determining the transfection yield is still 
a matter of debate. 
We have designed a new cationic lipid (vectamidine) capa- 
ble of transfecting DNA [1] and mRNA [8] into mammalian 
cells with high efficiency. In contrast o many other cationic 
compounds, the positive charge of vectamidine is associated 
with an amidine function rather than an amine. This feature 
may explain the novel properties of the DNA vectamidinc 
complex in transfection studies. Therel\~re, we compared vec- 
tamidine with two other commercial cationic lipid reagents 
(lipofectin and DMRIE-C), at the level of DNA uptake and 
transgene xpression efficiency in the COS cell line. Interest- 
ingly, no correlation was found between these two parameters. 
Electron microscopy revealed that for the three different cat- 
ionic compounds, DNA cationic lipid complexes were located 
in endosomal structures. However, most endosomal mem- 
branes in contact with DNA vectamidine complexes (84% 
of cases) and several with DNA DMRIE-C complexes (64% 
of cases), were discontinuous or absent. Endosomes contain- 
ing DNA-lipofectin complexes exhibited disrupted structure 
much less frequently (21% of casesl. More importantly, the 
frequency of the observed endosomal destabilization by the 
DNA cationic lipid complex can be directly correlated to the 
efficiency of transfection mediated by the cationic lipid. 
2. Materials and methods 
2. l. Reagents 
Vectamidine tdiC14-amidine) was synthesized as described [1] and is 
available from Biotech. Tools (Brussels, Belgium). Vectamidine lip- 
osomes were prepared by the ethanol injection method [8]. [:~2P]dCTP 
and the DNasel/DNA polymerase mixture (cat.no. N 5000) were 
from Amersham. Lipofectin and DMRIE-C were purchased from 
Gibco BRL. I)NA polymerase I was obtained from Boehringer 
Mannheim. 
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2.2. Labeling of plasmid DNA with [3eP]dCTP 
The plasmid DNA pCMV-CAT (containing the chloramphenicol 
acetyl transferase, CAT, bacterial gene under the control of the 
CMV immediate arly promoter/enhancer) was kindly provided by 
Dr. R. Debs and was previously described [12]. The pCMV-CAT 
plasmid DNA was purified using a Quiagene kit according to the 
manufacturer's instructions. To label the pCMV-CAT plasmid 
DNA with a2p, we used a modified nick translation technique: a
100 btl reaction mixture was prepared to contain 50 mM Tris-HCl, 
pH 7.5, 10 mM MgSO4, 0.1 mM DTT, 50 lag/ml BSA, 0.1 mM dATP, 
0.1 mM dGTP, 0.1 mM dTTP, 10 lag DNA, 2 lal (10 U/lal) DNA 
polymerase I, 2 lal of the DNA polymerase I/DNaseI mixture and 5 ILl 
of 3000 Ci/mmol [32p]dCTP. Under these conditions, the low DNaseI/ 
DNA ratio and the increased DNA polymerase/DNaseI ratio allows 
incorporation of the labeled nucleotide into the plasmid DNA without 
significant alteration of plasmid integrity as assessed by agarose gel 
electrophoresis. Radiolabeled plasmid DNA was separated from non- 
incorporated [a2p]dCTP by chromatography using a G50 column 
(Pharmacia) according to manufacturer's in tructions. 
2.3. Cell culture 
COS cells from the American Type Culture Collection (Rockville, 
MD) were grown in DMEM supplemented with 10% FBS, 1 mM 
pyruvate, 2 mM glutamine, 100 lag/ml kanamycin and non-essential 
amino acids in a 5% CO2 atmosphere. Cells were passaged every 
2 days. 
2.4. Transfection and reporter gene assay procedures 
Tranfection of cells was performed as described [1] with some mod- 
ifications. Briefly, cells were plated in 6-well plates at 4 x 105 cells per 
well 20-24 h before transfection. To prepare transfection c mplexes, 
1 lag of DNA and the desired amount of lipid (2 lag of vectamidine, 
5 lag of lipofectin or 10 lag of DMRIE-C) were separately diluted in 
50 lal of HBS at room temperature. They were mixed by pipetting up 
and down 3 times and incubated 15-20 min at room temperature. 
During this incubation time, cells were rinsed once and incubated in 
medium-free serum. The DNA-cationic lipid complexes were then 
diluted in 900 pl of medium-free s rum and applied to cells for 4 h. 
At the end of the incubation, complexes were aspirated, cells trypsi- 
nized and transferred to 9-cm-diameter plates in 10 ml of serum-con- 
taining medium. About 48 h post-transfection, cells were washed 
2 times with PBS and scraped in PBS with a rubber policeman. Cells 
were divided into two fractions and pelleted by centrifugation at4°C. 
The first cell pellet was resuspended in 50 ~tl of 250 mM Tris-HC1, pH 
7.8, and the cells were lyzed by three freeze-thawing cycles, heated for 
5 min at 60°C and assayed for CAT activity as described [1]. Quanti- 
fication of acetylated chloramphenicol was performed using the Phos- 
phor Imager (Molecular Dynamics). The second cell pellet was lyzed 
in 50 lal of 0.5°/,, Triton X-100 in PBS and assayed for protein con- 
centration using the DC-protein assay (BioRad). CAT activity was 
expressed as pmoles of acetylated chloramphenicol/lag cell protein/h 
(CAT units). 
2.5. DNA uptake measurement 
In these experiments, 32p-labeled plasmid DNA was used. DNA- 
lipid complexes were prepared and incubated with cells as described 
above. At the end of incubation with complexes, cells were washed 
3 times with medium-free serum and once with the trypsin solution 
(Life Technology), then detached by trypsin treatment and pelleted by 
centrifugation followed by washing with PBS. This treatment allowed 
removal of complexes that are weakly attached to cell. Finally, cells 
were lyzed in 200 lal of buffer containing 10 mM Tris-HCl, pH 8, 
150 mM NaC1, 10 mM EDTA, 0.5% SDS. The cell lysates were 
aspirated several times throughout a 0.4× 12 mm syringe needle to 
disrupt viscosity then 50 lal of the lysate was mixed with 5 ml of 
Aquasol2 scintillation cocktail (Dupont) and the a2p radioactivity 
was counted. 
2.6. Electron microscopy 
2.6.1. Vectamidine-DNA complex. Liposomes and DNA-lipo- 
some complexes were identified by transmission electron microscope 
(TEM) using a negative staining technique. Drops (50 I11) of freshly 
prepared samples were floated on collodion/carbon-coated 200 mesh 
nickel grids for 5 min. After washing for 30 s in PBS, the grids were 
incubated for 5-10 min with 2% phosphotungstic acid (pH 6.8). This 
solution was wicked off with filter paper and the grids were allowed to 
dry. 
2.6.2. Interaction of DNA cationic lipid complexes with 
cells. Transfected or untransfected COS cell cultures were scraped 
off the plates and centrifuged at 350xg for 3 min to form pellets. 
Small fragments of the various pellets were fixed for 30 min at room 
temperature in 2.5% glutaraldehyde in 0.1 M Sorensen's buffer (pH 
7.4). After washing in buffer, cells were post-fixed in 2% OsO4 for 30 
min at room temperature, dehydrated in ethanol (30%, 1 x 10 min; 
70%, 3x10 min) and embedded in Epon 812 resin (70% ethanol/ 
Epon, 1:1, 2×10 min; 70% ethanol/Epon, 1:2, 2×10 min; pure 
Epon, overnight). The polymerization was achieved at 60°C. Ultrathin 
sections (90 nm) were placed on 200 mesh nickel grids and stained 
with uranyl acetate and Reynold's lead citrate. The samples were 
examined in a Jeol CX 100 electron microscope at 60 kV. 
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Fig. 1. Comparison of DNA uptake efficiency (% of cell-associated 
DNA) and transfection efficiency (CAT activity) in COS cells. Cells 
were plated in a 6-well multidishes at 4x 105 cells per well (-+ 24 h 
prior the time of transfection) then transfected for 4 h, using 1 lag 
of pCMV-CAT plasmid DNA and 2, 5 or 10 lag of Vectamidine, 
Lipofectin or DMRIE-C, respectively (for details, see Section 2). 48 
h after transfection, cells were harvested and CAT activity quanti- 
tated (expressed as pmoles of acetylated chloramphenicol/lag cell 
protein/h=CAT units). B: Results are expressed as means+SD 
from 2 different triplicate experiments. For DNA uptake measure- 
ments, 32P-labelled pCMV-CAT plasmid DNA was used and cell-as- 
sociated 32p radioactivity measured at the end of the 4 h complexes 
incubation with cells (A). DNA uptake efficiency was expressed as 
the % of cell-associated DNA/mg of cell proteins. Results are x- 
pressed as means + SD from 2 different triplicate xperiments. 
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Fig. 2. Thin-section electron micrographs of COS cells transfected for 3 h with DNA Vectamidine complexes. The complexes appear as dark 
aggregated ovoid structures formed by a pile of membranes. The complexes are bound to the plasma membranes (A) or/and included in endo- 
somes (B). At the contact sites with the complexes, the plasma and endosomal membranes are frequently not visible (arrows). Most of com- 
plexes intruded into the cytoplasm are not or only partially surrounded by the endosomal membrane (arrowheads). Bars: 0.2 ~tm. 
3. Results 
3.1. Comparison between DNA uptake and transfection 
efficiency using vectamidine, lipofectin and DMRIE-C 
In order to establish a correlation between the transfection 
efficiency and the uptake of DNA mediated by cationic lipids, 
COS cells were transfected with plasmid DNA containing the 
chloramphenicol  acetyl transferase gene (pCMV-CAT) using 
vectamidine, lipofectin or DMRIE -C  (at 2:1, 5:1 and 10:1; 
lipid to DNA weight ratios, respectively), and CAT activity 
was quantitated. The percentage of DNA comprised in the 
transfection complexes, under the l ip id/DNA ratios used 
here, is close to 100% in all cases as evidenced by sucrose 
gradient analysis of the complexes (result not shown). In par- 
allel, DNA uptake efficiency was measured using 32p-labeled 
pCMV-CAT.  Compar ison of Figs. 1A and 1B clearly shows 
that there is no obvious correlation between the level of DNA 
uptake and transfection efficiency. This is evident for vecta- 
Table 1 
midine, for which a weak uptake results in an unexpected high 
level of transfection. This result suggests that vectamidine may 
be more efficient in the steps following the DNA uptake step. 
Alternatively, vectamidine-mediated DNA delivery into the 
cells could proceed through a different pathway. The entry 
of the three DNA-cat ion ic  lipid complexes into cells was 
studied by electron microscopy. 
3.2. Study of the pathway of DNA-cationic lipid complexes 
entry into cells by electron microscopy. 
Ultrathin sections from transfected or untransfected cells 
were prepared and processed for TEM as described in Section 
2. The complexes were identified by their higher electron den- 
sity after staining, vectamid ine-DNA complexes appeared as 
an aggregation of ovoid structures of multi lamellar lipid mem- 
branes (Fig. 2). This observation on ultrathin section was 
confirmed by negative staining of vectamidine DNA com- 
plexes adsorbed on a microscope grid (data not shown). The 
A Frequency of cell membranes destabilization and disruption at the complex attachment site 
Frequency of membrane disruption at the complex attachment site 
Vectamidine DMRIE-C Lipofectin 
Plasma membrane 76% n = 41 28% n = 32 25% n = 71 
Endosomes 81% n=32 64% n= 14 21% n=24 
B Evaluation of intracellular complexes as compared to total cell-associated complexes 
Distribution of complexes in COS cells 
Liposomes included in complexes at the cell surface 523 2905 1087 
Liposomes included in complexes inside the cells 122 (18%) 897 (23%) 324 (23%) 
A: COS cells were transfected with the DNA-cationic lipid complexes and ultrathin sections were prepared and observed by TEM as described in 
Section 2. For each lipid type, a number (n) of complexes, visible on ultrathin sections, either attached at the plasma membrane or included into 
endosomes, were randomly chosen. Among these complexes, those showing membrane destabilization and direct contact with the cytosol were 
counted and percentage of destabilization was obtained by dividing the obtained value by the total number (n) of complexes. 
B: 20 different ultrathin sections from cells transfected with vectamidine, lipofectin or DMRIE-C were selected to contain complexes• The total 
number of liposomes included in complexes that are attached to the cell surface and liposomes included in complexes that are located inside the cell 
cytoplasm were counted. The percentage of intracellular complexes (indicated in parentheses) i  expressed as the ratio of intracellular liposomes 
included in complexes versus total liposomes included in complexes (liposomes included in cytoplasmic plus cell surface attached complexes). 
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Fig. 3. Thin-section electron micrographs of COS cells transfected for 6 h with DNA DMRIE-C complexes. The complexes look like aggrega- 
tion of round plurilamellar hollow structures. A: General view of a COS cell showing many complexes bound to the cell surface or included in 
endosomal vesicles. B: Detail of a COS cell showing complexes in close contact with the plasma membrane or in endosomes. While the plasma 
membrane often seems continuous at the complex attachment site, discontinuities of endosomal membrane appear at the contact site with com- 
plexes (arrowheads). C: Detail of a COS cell showing a large and non-membrane-bound aggregate of complexes in the cytoplasm near the Gol- 
gi apparatus (G). Heavily stained membrane segments lie in the surrounding regions and seems derived from the complexes (arrows). N: nu- 
cleus, M: mitochondria. Bars: 0.2 lam. 
size of individual iposomes entrapped in the aggregate (aver- 
age: 240 + 94 nm; n = 50) was in agreement with our previous 
dynamic laser light scattering results [8]. In some cells, these 
structures were bound to the plasma membranes (Fig. 2A) 
and/or included in endosomal vesicles (Fig. 2B). Occasionally, 
some structures were also seen associated with coated pits. 
The plasma or endosomal membrane was very often inter- 
rupted at contact sites with the DNA-vectamidine complexes 
(Fig. 2, arrows). Most of the complexes intruded into the 
cytoplasm were free or only partially surrounded by the endo- 
somal membrane (Fig. 2B, arrowheads). In order to quanti- 
tate this observation, a number (n) of complexes were chosen 
randomly and those showing cell membrane destabilization 
and direct contact with cytoplasm were counted. Results are 
summarized in Table 1A. Plasma and endosomal membranes 
were found to be destabilized when in contact with vectami- 
d ine-DNA complexes in 76% (n=41) and 81% (n=32) of 
cases, respectively. However, a background should be sub- 
tracted from this values. Indeed, cell membranes were not 
always visible, even in regions devoid of complexes. This is 
most likely because of an artifact due to a vanishing contrast 
when the membrane is tilted with respect o the section plane. 
The same TEM approach was applied to cells transfected 
with lipofectin or DMRIE-C.  On ultrathin sections, DNA-  
DMRIE -C  complexes appeared as an aggregation of round, 
plurilamellar and hollow structures (Fig. 3) whereas DNA 
lipofectin complexes appeared as an aggregation of dark, 
ovoid plurilamellar and hairy particles (Fig. 4). The average 
size of individual DMRIE -C  and lipofectin liposomes was 
smaller than that of DNA~ectamid ine  liposomes (198_+ 80 
nm (n = 50) for DMRIE -C  and 148 + 53 nm (n = 50) for lip- 
ofectin as compared with 240 nm for vectamidine). Both 
DNA-DMRIE -C  and DNA-l ipofect in complexes were bound 
to the cell surface and were taken up by endocytosis. Inter- 
action of the DNA-l ipofectin complexes with the cells was 
frequently observed at coated pits. 
In contrast to DNA-vectamidine complexes, which were 
detected in a small fraction of cells (only 2%, out of 160 
randomly chosen ultrathin sections, contained complexes), 
DNA lipofectin and DNA-DMRIE -C  complexes were de- 
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Fig. 4. Thin-section electron micrographs of COS cells transfected for 6 h with DNA Lipofectin complexes. The complexes appear as aggre- 
gated, dark, ovoid, plurilamellar nd hairy particles. Such particles are found at the cell surface (A) and in endosomal vesicles (B). Both plasma 
and endosomal membranes most often seems continuous at the complex attachment site. Arrow indicates a coat dpit. N: nucleus. Bars: 0.2 
J, tm. 
tected in nearly all cells (96% and 94% for lipofectin and 
DMRIE-C, respectively, out of 122 randomly chosen ultrathin 
sections for each lipid, contained complexes). Moreover, the 
number of complexes per cell was significantly higher in the 
case of DMRIE-C and lipofectin as compared to vectamidine 
(Table I B). These results are in agreement with the [;~2P]DNA 
uptake measurement (Fig. 1A). 
It was also interesting to note that with these two cationic 
lipids the plasma membrane often seemed continuous at the 
complex attachment site. Indeed, there was only 25 28% 
(n = 103) of situations where discontinuity appeared as com- 
pared with 76% for vectamidine. In the case of DMRIE-C, 
however, a 64% (n--14) frequency of disruption at the com- 
plex attachment site in the endosome was observed. This dis- 
ruption of endosomes was much less frequently observed 
(21"/,,, n=24) with the DNA lipofectin complexes. Finally, 
these two cationic lipid DNA complexes were also found in 
large membrane-bound vesicles near the Golgi apparatus and 
none were observed in the nucleus. 
4. Discussion 
The use of cationic lipids as DNA delivery systems for gene 
therapy is still limited by the relative inefficiency of the gene 
transfer process compared with viral vectors (i.e. adenovirus). 
Understanding the cellular pathways and limitations of the 
cationic lipid-mediated gene transfer could allow the design 
of more efficient cationic vectors. We compare here vectami- 
dine with two reference compounds (lipofectin and DMRIE- 
C) regarding the DNA uptake efficiency and transgene expres- 
sion efficiency of the corresponding DNA-lipid complexes. An 
interesting feature are the observed differences in complex 
morphology on ultrathin sections, when using different cati- 
onic lipids. At present, we do not know whether these differ- 
ences in complex morphology affect their interaction with 
cells, but this aspect surely merits further investigations. 
The first step in cationic lipid-mediated DNA transfection is 
the capture and uptake of the cationic lipid-DNA complexes 
by the cell. This process may be influenced by several param- 
eters such as the c arge and the size of the complexes [14,25]. 
It was suggested that large DNA-~zationic liposome complexes 
are not efficiently taken up by the cell [25]. Electron micros- 
copy showed that vectamidine t nds to form large complexes 
with DNA. This could explain, at least in part, the lower 
DNA uptake observed with vectamidine in the cell line tested 
here. It is clear that our [;~2P]DNA uptake measurement (Fig. 
IA) did not allow discrimination between internalized DNA 
lipid complexes and cell surface-bound complexes. However, 
Table 1B shows that the percentage of intracellular complexes 
relative to total cell-associated complexes is similar for each 
compound and is close to 20%,. 
The fact that DNA uptake efficiency did not necessarily 
lead to transgene xpression efficiency (Fig. 1), clearly indi- 
cates that the uptake step is not the single limiting factor in 
transfection. Electron microscopy supported the idea that for 
all cationic lipids studied here, endocytosis the main path- 
way of complex internalization by the cells. Moreover, the 
endosomal membranes were often discontinuous and absent 
in contact with DNA-vectamidine and DNA DMRIE-C 
complexes. Endosomes containing DNA lipofectin complexes 
less frequentl~ exhibited this disrupted morphology. This sug- 
gests that vectamidine and DMRIE-C are more efficient in 
promoting escape of complexes from endosomes than was 
lipofectin and may explain the relative inefficiency of lipofec- 
tin, compared to vectamidine and DMRIE-C, in terms of 
transgene xpression. Indeed, only complexes that escape 
from endosomes are expected to deliver their DNA to the 
cytoplasm and thus permit its entry into the nucleus and fi- 
nally expression [23,26,28]. 
The plasma membrane was also often absent when in con- 
tact with DNA vectamidine complexes and some complexes 
were found to be free in the cytoplasm. This suggests that, in 
the case of vectamidine, a direct translocation across the plas- 
ma membrane may be also involved in the complex entry into 
the cytoplasm. The frequency of such a mechanism is difficult 
to estimate relative to the endocytosis pathway with TEM 
[22,23]. Indeed, such an event is expected to be faster than 
endocytosis which would prevent its detection by electron 
microscopy. 
Fusion between the cationic liposome of the complex and 
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the endosomal membrane has been proposed to explain the 
mechanism of endosomal escape and DOPE has been sug- 
gested to play a major role in the fusion process 
[23,24,26,29]. It is worth mentioning that both vectamidine 
and DMRIE-C contained a C14 hydrocarbon chain, but no 
DOPE, and were efficient in promoting complex escape from 
endosomes and transgene xpression. This suggests that the 
interaction between cationic lipids containing a short satu- 
rated hydrocarbon chain and endosomal membranes may in-
volve a different mechanism than the previously suggested 
DOPE-mediated fusion mechanism. Recent data support the 
idea that lipid fusion can occur even in the absence of DOPE 
[30]. 
In conclusion, this study reveals several important observa- 
tions. Endocytosis is the major pathway of DNA-cationic 
lipid complex uptake by COS cells. Large DNA~zationic lipid 
complexes are not efficiently taken up by cells. However, the 
uptake efficiency is not the rate-limiting step of transfection i  
our case. The ability to destabilize and escape from endo- 
somes/lysosomes, crucial for transfection, could be correlated 
with the presence of a short (C14) saturated hydrocarbon 
chain in the hydrophobic domain of the cationic lipid and 
to a lesser extent, to the presence of DOPE as a helper lipid. 
With vectamidine, a high transfection efficiency was observed 
despite the absence of DOPE and a low amount of cell-asso- 
ciated DNA. 
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